MED1 is a core component of the Mediator complex, a coactivator essential for regulated transcription of RNA polymerase II-dependent genes 123. MED1 functions as a transcriptional bridge, conveying signals from gene-specific regulatory proteins to basal RNA polymerase II machinery and facilitating preinitiation complex assembly 4. Mechanistically, MED1 contains intrinsically disordered regions that enable phase separation, forming nuclear condensates at super-enhancers where it concentrates transcriptional machinery to drive robust gene expression 5. MED1 also acts as a pH-sensitive regulator; acidic pH disrupts BRD4-MED1 condensates via histidine-rich regions, providing negative feedback on inflammatory responses 6. In disease contexts, MED1 dysfunction is implicated in pulmonary arterial hypertension, where decreased MED1 levels impair BMP/TGF-β signaling in endothelium 7. In cancer, MED1 enrichment at super-enhancers drives oncogene overexpression in head and neck squamous cell carcinoma, making it a therapeutic target 8. Additionally, MED1 participates in phase-separated transcriptional activation through interaction with pathway-specific transcription factors like TAZ 9. Clinically, understanding MED1's condensate dynamics and its role in cell-identity gene regulation offers insights for developing targeted therapies.